Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04641026 · ClinicalTrials.gov registry record · NA
Discovery of Biological Signatures for Cruciferous Vegetable Intake (Single Serving)
A NA study of Diet, Healthy, sponsored by Oregon State University.
- Active
- Registry status
- NA
- Development phase
- 83
- Enrollment target
- 1
- Study location
NCT04641026: Active NA study of Diet, Healthy, sponsored by Oregon State University.
NCT04641026 is a NA study of Diet, Healthy that is active but no longer recruiting, run by Oregon State University. The registered enrollment target is 83 participants, below the 506-participant average among 48 other Diet, Healthy trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04641026, a NA study of Diet, Healthy, is active but no longer recruiting, sponsored by Oregon State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to study the molecular and metabolic profiles in human plasma, urine and microbiome composition following the consumption of broccoli sprouts.
Primary Outcome
Change in levels of sulforaphane metabolites in urine
Conditions Studied
Interventions
- OTHER Broccoli sprouts
- OTHER Deuterium oxide-labelled broccoli sprouts
- OTHER Alfalfa sprouts
- OTHER Deuterium oxide-labelled alfalfa sprouts
Study Locations (1)
Oregon
- Oregon State University - Corvallis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2021-02-22 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT04641026 still lists
NCT04641026 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 506-participant average among 48 other Diet, Healthy trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Diet, Healthy appearing as the primary indexed condition, and to 4 interventions - of which Broccoli sprouts is the first listed.
NCT04641026 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04641026 about?
NCT04641026 is a clinical study titled "Discovery of Biological Signatures for Cruciferous Vegetable Intake (Single Serving)". The purpose of this project is to study the molecular and metabolic profiles in human plasma, urine and microbiome composition following the consumption of broccoli sprouts.
What is the current status of trial NCT04641026?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 83 participants. The study started on 2021-02-22. Estimated completion is 2026-12.
What conditions does trial NCT04641026 study?
This clinical trial studies the following conditions: Diet, Healthy.
What interventions are being tested in trial NCT04641026?
The interventions under investigation include: Broccoli sprouts (OTHER), Deuterium oxide-labelled broccoli sprouts (OTHER), Alfalfa sprouts (OTHER), Deuterium oxide-labelled alfalfa sprouts (OTHER).
Who is sponsoring clinical trial NCT04641026?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04641026 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diet, Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04641026's enrollment target sits among peer trials
83 28th of 48 higher than 21 of 48 other Diet, Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diet, Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sip and Snack Better (SSB) Study: Improving Added Sugar in Adolescents
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Medically Tailored Meals for Cardiovascular Health
RECRUITING · NA
-
Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI